FDA Has Approved A New Medication Treatment For Migraines In Adults

Updated Feb 6, 2025 | 05:09 PM IST

SummaryMany people use the terms ‘migraine’ and ‘headache’ interchangeably. This leads many people to believe that migraines are not as serious as people make them out to be, and that cannot be more wrong, migraines have a major effect on a person’s lifestyle and the new approved medication may prove to be a great relief!
(Credit-Canva)

(Credit-Canva)

Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

End of Article

Olivia Munn, Senator Mark Kelly Push For Breast Cancer Bill In US: What To Know

Updated Nov 19, 2026 | 09:49 PM IST

SummaryOlivia Munn and US Senator Mark Kelly have introduced the Know Your Risk Act to expand access to validated breast cancer risk assessment tools, helping women and their doctors understand individual risk and make informed screening decisions.
Olivia Munn, Senator Mark Kelly Push For Breast Cancer Bill In US: What To Know

Credit: Mark Kelly/X

Actress Olivia Munn has joined US Senator Mark Kelly to push for legislation that would make breast cancer risk assessments a routine part of healthcare for American women, helping them understand their individual risk and access appropriate screening.

Together, they have introduced the Know Your Risk Act, which aims to expand access to validated breast cancer risk assessment tools and integrate them into routine healthcare.

Munn, who was diagnosed with breast cancer in 2023, said a risk assessment prompted her doctor to recommend further testing despite her having a normal mammogram and negative genetic testing. The additional tests detected an aggressive cancer early.

"Had it not been for that assessment, my breast cancer may not have been identified when it was," Munn said while announcing the legislation alongside Kelly.

Also read: World Breast Cancer Day 2026: Life After Breast Cancer, The Fear No One Sees

What Is The Know Your Risk Act?

Announcing the legislation outside the US Capitol, Kelly said existing breast cancer risk assessment tools are not being used widely enough, leaving many women unaware of their individual risk.

"These tools already exist, but too often doctors aren't using them and women don't know that they're available," Kelly said.

The Democratic senator from Arizona said the Act would make breast cancer risk assessments a routine part of healthcare, helping women and their doctors understand individual risk and determine appropriate screening.

"Women shouldn't have to ask for these assessments. They should be part of regular care like getting a blood pressure reading taken," Kelly said.

He added that the legislation had bipartisan support, with lawmakers recognizing the importance of expanding access to early detection.

Why Is Breast Cancer Risk Assessment Important?

Read More: Breast Cancer At 26 Sent This US Woman Into Menopause Before 30: What Is The Hidden Toll Of Treatment

Munn's experience highlights why individual risk assessments matter, particularly when standard screening and genetic testing may not identify a woman's breast cancer risk.

Despite having a normal mammogram and negative genetic testing, her risk assessment prompted further investigations that led to her diagnosis.

She said the experience motivated her to work with Kelly to ensure other women have access to similar assessments.

According to the World Health Organization (WHO), breast cancer caused an estimated 694,000 deaths worldwide in 2024. It was the most commonly diagnosed cancer among women in 164 of 186 countries.

In the US, breast cancer is the second leading cause of cancer death among women, according to the Centers for Disease Control and Prevention (CDC).

Early Breast Cancer Detection Can Improve Survival

Early detection can significantly improve breast cancer outcomes. According to the National Cancer Institute, the five-year relative survival rate for women with localized breast cancer is more than 99%.

During the announcement, a representative of breast cancer organization Susan G. Komen highlighted the difference between detecting the disease before and after it spreads, noting that survival rates can fall to around 30% when breast cancer is diagnosed at a distant stage.

The representative also pointed to the rising number of diagnoses among women under 50, many of whom may not consider themselves at risk.

The Know Your Risk Act seeks to address this gap by expanding access to validated risk assessment tools, helping women and their doctors better understand individual risk and make informed decisions about screening.

End of Article

New US Organ Donation Rules Require Five-Minute Wait As Patients Show Signs Of Life Before Organ Recovery

Updated Nov 19, 2026 | 10:00 PM IST

SummaryUnder Health Resources and Services Administration (HRSA) and the Organ Procurement and Transplantation Network (OPTN), new safeguards around organ donation have been implemented to ensure death has been confirmed adequately before organ recovery begins.
New US Organ Donation Rules Require Five-Minute Wait As Patients Show Signs Of Life Before Organ Recovery

Credit: AI

New rules to govern organ donation in the United States went into effect from Wednesday, November 18, 2026. According to the latest safeguards, before organ recovery can begin, a minimum five-minute observation period is mandatory after a patient's circulation stops.

The rules come amid concerns about patients showing signs of neurological activity during the organ recovery procedure and also whether it had been adequately confirmed that the patient died.

The rules apply to donation after circulatory death (DCD), a process in which organs may be recovered after a patient's heart and circulation have stopped. They are not applicable to every form of organ donation.

The new requirements were developed under the Health Resources and Services Administration (HRSA) and the Organ Procurement and Transplantation Network (OPTN). They include additional safeguards, including stronger and clearer neurological checks, a formal process to pause donation when safety concerns arise, and more transparent communication with families.

Patients Showed Neurological Activity During Organ Removal

The changes come after HRSA probed into organ procurement systems. In July 2025, the US Department of Health and Human Services said it had examined 351 cases in which organ donation had been authorised but ultimately did not proceed.

The review found concerning details in 103 cases, including 73 patients who showed neurological signs that were considered incompatible with organ donation. It also found that at least 28 patients may not have been deceased when organ recovery was initiated.

On a wider front, the investigation sparked questions about the inadequacy of neurological assessments, coordination between hospitals and organ procurement organisations, and the documentation of death. HRSA subsequently directed the OPTN to strengthen safeguards across the donation process.

Also read: Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

A Mandatory Five-Minute Waiting Rule

Under the new policy, an observation period of at least five minutes must pass after circulation has ceased before organ recovery can begin.

The aim is to confirm that the heart does not restart spontaneously, a rare phenomenon called autoresuscitation. It is also sometimes called the Lazarus phenomenon.

In DCD, a patient's life-saving treatment is stopped after a decision made by the patient or their legally authorised representative in consultation with the doctors.

If the patient dies after their heart and circulation stop, organ donation may proceed after death has been determined with complete certainty and the mandatory observation period completed.

Also read: Life At Any Cost: Why We Fight To Prolong Life But Question The Idea To Ease Death?

Other Organ Donation Safeguards

Apart from the five-minute observation period, the new also include:

  • A formal pause request: Families, healthcare professionals and other people involved in the process can request a pause if concerns about patient's safety surface.
  • Clear procedures for pauses: Hospitals and organ procurement organisations must follow prescribed steps to resolve concerns before donation is resumed.
  • Reporting of pauses: Requested unplanned pauses must be documented carefully and reported to improve transparency.
  • Better neurological assessment records: Hospitals must document neurological assessments. Discrepancies between hospital assessments and observations by organ procurement organisations requiring escalation.
  • Better family communication: Families must receive more comprehensive information about the donation process to support informed decision-making.

End of Article

After US Loses Measles Elimination Status, Senators Call Out RFK Jr. Over Vaccine Policies

Updated Nov 19, 2026 | 09:47 PM IST

SummaryThe Pan American Health Organization (PAHO) confirmed that the US had lost the status it maintained since 2000. ​The country has recorded more than 5,700 measles cases and 11 deaths. Pennsylvania, the hardest-hit state, has reported its eighth measles-associated death of 2026.
After US Loses Measles Elimination Status, Senators Call Out RFK Jr. Over Vaccine Policies

Credit: AP Photos

After 26 years, the US has lost its measles elimination status, marking a major setback for public health efforts. The resurgence has intensified criticism of Health and Human Services Secretary Robert F. Kennedy Jr. over his vaccine policies and rhetoric.

The Pan American Health Organization (PAHO) confirmed that the US had lost the status it maintained since 2000.

The country has recorded more than 5,700 measles cases and 11 deaths. Pennsylvania, the hardest-hit state, has reported its eighth measles-associated death of 2026.

Measles Infections Among Pregnant Women, Newborns Raise Concern

A CDC-led report identified 112 measles infections among pregnant women in the US between January 2025 and September 2026, along with 13 cases of congenital measles in newborns.

The actual number may be higher. A separate CIDRAP News investigation based on state health department data identified at least 167 pregnant women infected in 2025 and 2026.

“Even though measles is an old disease, measles in pregnancy is an emerging area that we need to learn about,” said Michelle Barton, a professor at the Schulich School of Medicine & Dentistry at Western University.

Decades of MMR vaccination meant many doctors had never encountered measles during their medical careers. However, declining vaccination rates have allowed the disease to spread in under-vaccinated communities.

Also read: US Loses Measles-Elimination Status After 26 Years: Prof Devi Sridhar Explains Reasons Behind Resurgence

US Senators Criticise RFK Jr.

Criticism of Kennedy has crossed party lines. Republican Senator Bill Cassidy of Louisiana on Sunday criticised what he called a "series of failures" under Kennedy's leadership at the Department of Health and Human Services.

"This has been a failure. If I were president, I would choose someone else because there needs to be accountability for higher health care costs, more measles deaths, losing elimination status, and no progress on processed foods," Cassidy said on CBS News.

Democratic senators Angela Alsobrooks and Patty Murray have also called for Kennedy's removal.

Alsobrooks (Maryland) condemned the loss of measles elimination status and called Kennedy's tenure a disgrace. She had called for his resignation or dismissal in May 2025. Her resolution of disapproval against Kennedy now has 28 Senate co-sponsors.

Senator Richard Blumenthal (Connecticut) has demanded answers over the alleged suppression of a CDC warning about measles risks during pregnancy, while criticising the administration's vaccine policies.

Murray (Washington) has blamed Trump and Kennedy's leadership for the loss of elimination status and repeatedly called for Kennedy's removal.

Read More: What Happens After Measles Infection? The Hidden Risks That Can Last For Years

Governors Demand Kennedy's Removal

Democratic governors have also blamed Kennedy for the setback. New York Governor Kathy Hochul said the loss of measles elimination status contradicted Kennedy's promise to make America healthy again.

"RFK Jr. promised to 'Make America Healthy Again.' Now America has lost its measles-free status for the first time in 26 years," Hochul said.

"A disgraceful display of incompetence from the nation's highest public health office," she added.

Pennsylvania Governor Josh Shapiro blamed vaccine misinformation and skepticism for the setback. "There is a clear line from the misinformation, vaccine skepticism, and incompetence of RFK Jr. to this devastating news and very real consequences," Shapiro said.

Kentucky Governor Andy Beshear explicitly demanded Kennedy's removal. "This dangerous setback was 100% avoidable and is the result of one person: RFK Jr.," Beshear said. "Remove him now."

An HHS spokesperson rejected the governors' criticism in a statement to Fox News Digital, calling their attacks "baseless" and arguing that declining vaccination rates predated the Trump administration.

The spokesperson said the administration remained focused on expanding vaccine access, closing immunisation gaps and assisting state and local officials with outbreak investigations.

What Has RFK Jr. Said?

Kennedy has vowed to stop measles outbreaks and restore the country's elimination status while continuing to recommend vaccination.

"We will stop measles outbreaks, protect American families, and work to regain U.S. measles elimination status," Kennedy said in a statement.

"I continue to recommend MMR vaccination as the most effective way to prevent measles," he added.

End of Article